GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (FRA:DAN) » Definitions » Net Issuance of Debt

DanCann Pharma AS (FRA:DAN) Net Issuance of Debt : €-0.13 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DanCann Pharma AS Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. DanCann Pharma AS's net issuance of debt for the three months ended in Sep. 2024 was €0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.13 Mil.

DanCann Pharma AS Net Issuance of Debt Historical Data

The historical data trend for DanCann Pharma AS's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DanCann Pharma AS Net Issuance of Debt Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
Get a 7-Day Free Trial 0.20 -0.20 1.35 -0.33 0.40

DanCann Pharma AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 -0.43 - 0.30 -

DanCann Pharma AS Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DanCann Pharma AS Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of DanCann Pharma AS's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

DanCann Pharma AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (FRA:DAN) » Definitions » Net Issuance of Debt
Comparable Companies
XSAT:ARCEDE XSAT:ACUC OSTO:GABA OSTO:EMPLI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NBIX NSE:DIVISLAB BOM:500124 VTRS SZSE:000963 XPAR:IPN
Traded in Other Exchanges
DANCAN:Sweden
Address
Rugvaenget 5, Ansager, DNK, DK-6823
Website
https://www.dancann.com
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.